Related Experiment Video
Updated: Jun 23, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Multiple myeloma, IL6, and risk of schizophrenia: A Mendelian randomization, transcriptome, and Bayesian
Shuyang Lin1, Bei Gao2, Rui Xu3
1Division of Hematology, Department of Medicine Washington University School of Medicine in St Louis St Louis Missouri USA.
Abstract:
Numerous clinical studies speculated the association between multiple myeloma (MM) and inflammatory diseases; however, there is limited validation of these claims via establishing a causal relationship and revealing the underlying mechanism. This exploratory study employed bidirectional Mendelian randomization (MR) analysis to investigate the causal relationships between MM and inflammatory diseases, including atherosclerosis, asthma, ankylosing spondylitis, Alzheimer's disease (AD), Parkinson's disease (PD), sarcoidosis, inflammatory bowel disease, nonalcoholic fatty liver disease, type II diabetes, and schizophrenia (SZ). Transcriptomic and genome-wide Bayesian colocalization analyses were further applied to reveal the underlying mechanism. A significant and previously unrecognized positive association was identified between genetic predisposition to MM and the risk of SZ. Two independent case reports showed that treatment-resistant psychosis is due to underlying MM and is resolved by treating MM. From our MR analyses, various statistical methods confirmed this association without detecting heterogeneity or pleiotropy effects. Transcriptomic analysis revealed shared inflammation-relevant pathways in MM and SZ patients, suggesting inflammation as a potential pathophysiological mediator of MM's causal effect on SZ. Bayesian colocalization analysis identified rs9273086, which maps to the protein-coding region of HLA-DRB1, as a common risk variant for both MM and SZ. Polymorphism of the HLA-DRB1 allele has been implicated in AD and PD, further highlighting the impact of our results. Additionally, we confirmed that interleukin-6 (IL-6) is a risk factor for SZ through secondary MR, reinforcing the role of neuroinflammation in SZ etiology. Overall, our findings showed that genetic predisposition to MM, HLA-DRB1 polymorphism, and enhanced IL-6 signaling are associated with the increased risk of SZ, providing evidence for a causal role for neuroinflammation in SZ etiology.
Insights
Genetic links between multiple myeloma (MM) and schizophrenia (SZ) were explored. Findings suggest MM increases SZ risk, potentially mediated by inflammation and shared genetic factors like HLA-DRB1.
Area of Science:
- Genetics
- Neuroscience
- Oncology
Background:
- Clinical studies suggest links between multiple myeloma (MM) and inflammatory diseases, but causal relationships and mechanisms remain unclear.
- Investigating these associations is crucial for understanding disease pathogenesis and potential therapeutic targets.
Purpose of the Study:
- To investigate the causal relationships between multiple myeloma (MM) and various inflammatory diseases using bidirectional Mendelian randomization (MR).
- To identify underlying mechanisms connecting MM and inflammatory diseases, specifically focusing on schizophrenia (SZ).
Main Methods:
- Bidirectional Mendelian randomization (MR) analysis was employed to assess causal links between MM and inflammatory diseases.
- Transcriptomic and genome-wide Bayesian colocalization analyses were used to uncover shared biological pathways and genetic variants.
- Secondary MR analysis confirmed the role of interleukin-6 (IL-6) in SZ etiology.
Main Results:
- A significant positive association was found between genetic predisposition to MM and an increased risk of schizophrenia (SZ).
- Two case reports indicated treatment-resistant psychosis resolved upon MM treatment.
- Transcriptomic analysis revealed shared inflammation-relevant pathways in MM and SZ.
- Bayesian colocalization identified a common risk variant, rs9273086 in HLA-DRB1, for both MM and SZ.
- Interleukin-6 (IL-6) was confirmed as a risk factor for SZ.
Conclusions:
- Genetic predisposition to MM causally increases the risk of developing schizophrenia (SZ).
- Shared inflammation-relevant pathways and the HLA-DRB1 gene polymorphism mediate this association.
- Neuroinflammation, potentially involving IL-6, plays a significant role in the etiology of SZ in the context of MM.
Related Concept Videos
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Non-LTR Retrotransposons

